Alkermes Community
NasdaqGS:ALKS Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 6 Fair Values set on narratives written by author
Community Investing Ideas
AN
Consensus Narrative from 14 Analysts
INVEGA SUSTENNA Royalty Expiry Will Cause $215 Million Revenue Loss
Key Takeaways Expiration of INVEGA SUSTENNA royalty and loss of legacy revenues may significantly impact top-line growth. Increased R&D spending and competition in the psychiatric segment could pressure margins and dampen near-term EPS.
View narrativeUS$37.80
FV
28.3% undervalued intrinsic discount-2.81%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
about 1 month ago author updated this narrative